FOLD logo

Amicus Therapeutics, Inc. (FOLD) Accounts payable

annual accounts payable:

$12.95M-$2.17M(-14.37%)
December 31, 2024

Summary

  • As of today (September 17, 2025), FOLD annual accounts payable is $12.95 million, with the most recent change of -$2.17 million (-14.37%) on December 31, 2024.
  • During the last 3 years, FOLD annual accounts payable has fallen by -$8.57 million (-39.82%).
  • FOLD annual accounts payable is now -40.40% below its all-time high of $21.72 million, reached on December 31, 2019.

Performance

FOLD Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

quarterly accounts payable:

$13.89M-$558.00K(-3.86%)
June 30, 2025

Summary

  • As of today (September 17, 2025), FOLD quarterly accounts payable is $13.89 million, with the most recent change of -$558.00 thousand (-3.86%) on June 30, 2025.
  • Over the past year, FOLD quarterly accounts payable has dropped by -$18.16 million (-56.66%).
  • FOLD quarterly accounts payable is now -88.46% below its all-time high of $120.37 million, reached on December 31, 2019.

Performance

FOLD quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

FOLD Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-14.4%-56.7%
3 y3 years-39.8%-39.9%
5 y5 years-40.4%-2.9%

FOLD Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-39.8%at low-56.7%+50.9%
5 y5-year-40.4%at low-56.7%+50.9%
alltimeall time-40.4%+2342.8%-88.5%>+9999.0%

FOLD Accounts payable History

DateAnnualQuarterly
Jun 2025
-
$13.89M(-3.9%)
Mar 2025
-
$14.45M(+11.6%)
Dec 2024
$12.95M(-14.4%)
$12.95M(-4.0%)
Sep 2024
-
$13.48M(-57.9%)
Jun 2024
-
$32.06M(+248.1%)
Mar 2024
-
$9.21M(-39.1%)
Dec 2023
$15.12M(-1.9%)
$15.12M(-34.7%)
Sep 2023
-
$23.15M(+71.2%)
Jun 2023
-
$13.52M(-45.8%)
Mar 2023
-
$24.96M(+62.0%)
Dec 2022
$15.41M(-28.4%)
$15.41M(+28.0%)
Sep 2022
-
$12.05M(-47.9%)
Jun 2022
-
$23.11M(+0.9%)
Mar 2022
-
$22.91M(+6.5%)
Dec 2021
$21.51M(+26.1%)
$21.51M(-12.1%)
Sep 2021
-
$24.47M(+77.8%)
Jun 2021
-
$13.76M(-14.6%)
Mar 2021
-
$16.11M(-5.6%)
Dec 2020
$17.06M(-21.4%)
$17.06M(+15.6%)
Sep 2020
-
$14.76M(+3.2%)
Jun 2020
-
$14.31M(-11.9%)
Mar 2020
-
$16.24M(-86.5%)
Dec 2019
$21.72M(+228.8%)
$120.37M(+47.7%)
Sep 2019
-
$81.47M(-3.1%)
Jun 2019
-
$84.12M(+38.8%)
Mar 2019
-
$60.60M(-24.8%)
Dec 2018
$6.61M(-16.0%)
$80.63M(+48.4%)
Sep 2018
-
$54.33M(+30.6%)
Jun 2018
-
$41.61M(-4.7%)
Mar 2018
-
$43.68M(+455.2%)
Dec 2017
$7.87M(-39.0%)
$7.87M(>+9900.0%)
Sep 2017
-
$0.00(0.0%)
Jun 2017
-
$0.00(0.0%)
Mar 2017
-
$0.00(-100.0%)
Dec 2016
$12.90M(-21.7%)
$12.90M(-55.5%)
Sep 2016
-
$29.01M(+21.8%)
Jun 2016
-
$23.83M(>+9900.0%)
Mar 2016
-
$0.00(-100.0%)
DateAnnualQuarterly
Dec 2015
$16.48M(+180.5%)
$32.22M(+5.4%)
Sep 2015
-
$30.57M(+80.8%)
Jun 2015
-
$16.90M(+6.7%)
Mar 2015
-
$15.83M(-3.1%)
Dec 2014
$5.87M(+173.7%)
$16.34M(+44.3%)
Sep 2014
-
$11.33M(+14.2%)
Jun 2014
-
$9.92M(+8.2%)
Mar 2014
-
$9.17M(-9.8%)
Dec 2013
$2.15M(+1.5%)
$10.16M(+24.4%)
Sep 2013
-
$8.17M(-9.4%)
Jun 2013
-
$9.02M(+40.3%)
Mar 2013
-
$6.43M(-27.3%)
Dec 2012
$2.12M(-17.9%)
$8.85M(-6.2%)
Sep 2012
-
$9.43M(+4.0%)
Jun 2012
-
$9.07M(+7.3%)
Mar 2012
-
$8.45M(-13.0%)
Dec 2011
$2.58M(+30.7%)
$9.71M(+19.9%)
Sep 2011
-
$8.10M(+15.4%)
Jun 2011
-
$7.02M(-5.4%)
Mar 2011
-
$7.42M(-10.5%)
Dec 2010
$1.97M(-48.6%)
$8.29M(+21.8%)
Sep 2010
-
$6.81M(+18.4%)
Jun 2010
-
$5.75M(-21.8%)
Mar 2010
-
$7.36M(-23.6%)
Dec 2009
$3.84M(+93.1%)
$9.63M(-24.5%)
Sep 2009
-
$12.76M(+16.1%)
Jun 2009
-
$10.99M(+26.5%)
Mar 2009
-
$8.68M(+337.0%)
Dec 2008
$1.99M(+274.9%)
$1.99M(-79.7%)
Sep 2008
-
$9.80M(-8.8%)
Jun 2008
-
$10.74M(+923.3%)
Mar 2008
-
$1.05M(+98.1%)
Dec 2007
$530.00K(-55.7%)
$530.00K(-0.9%)
Sep 2007
-
$535.00K(+58.3%)
Jun 2007
-
$338.00K(-80.5%)
Mar 2007
-
$1.74M(+45.4%)
Dec 2006
$1.20M(+31.9%)
$1.20M(+31.9%)
Dec 2005
$906.20K(+53.6%)
$906.20K
Dec 2004
$589.90K
-

FAQ

  • What is Amicus Therapeutics, Inc. annual accounts payable?
  • What is the all time high annual accounts payable for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual accounts payable year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly accounts payable year-on-year change?

What is Amicus Therapeutics, Inc. annual accounts payable?

The current annual accounts payable of FOLD is $12.95M

What is the all time high annual accounts payable for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual accounts payable is $21.72M

What is Amicus Therapeutics, Inc. annual accounts payable year-on-year change?

Over the past year, FOLD annual accounts payable has changed by -$2.17M (-14.37%)

What is Amicus Therapeutics, Inc. quarterly accounts payable?

The current quarterly accounts payable of FOLD is $13.89M

What is the all time high quarterly accounts payable for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly accounts payable is $120.37M

What is Amicus Therapeutics, Inc. quarterly accounts payable year-on-year change?

Over the past year, FOLD quarterly accounts payable has changed by -$18.16M (-56.66%)
On this page